Verrica Pharmaceuticals Inc. Finance Lease, Right-of-Use Asset, Amortization
Verrica Pharmaceuticals Inc. (VRCA) reported Finance Lease, Right-of-Use Asset, Amortization of $113.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-06
- Verrica Pharmaceuticals Inc. finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $113.00K, a 39.51% increase year-over-year.
- Verrica Pharmaceuticals Inc. finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $100.00K, a 19.05% increase year-over-year.
- Verrica Pharmaceuticals Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $100.00K, a 27.01% decline year-over-year.
- Verrica Pharmaceuticals Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $88.00K, a 52.94% decline year-over-year.
- Verrica Pharmaceuticals Inc. finance lease, right-of-use asset, amortization for fiscal 2025 was $352.00K, a 43.13% decline from fiscal 2024.
- Verrica Pharmaceuticals Inc. finance lease, right-of-use asset, amortization for fiscal 2024 was $619.00K, a 2995.00% increase from fiscal 2023.
- Verrica Pharmaceuticals Inc. finance lease, right-of-use asset, amortization for fiscal 2023 was $20.00K.
- Verrica Pharmaceuticals Inc. finance lease, right-of-use asset, amortization for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 9 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 12 month | Finance Lease, Right-of-Use Asset, Amortization 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $113.00K 10-Q · filed 2026-08-06 | $213.00K 10-Q · filed 2026-08-06 | $313.00K derived: sum of 3 quarters · filed 2026-08-06 | $401.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-12 | $200.00K derived: sum of 2 quarters · filed 2026-05-12 | $288.00K derived: sum of 3 quarters · filed 2026-05-12 | $369.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $188.00K derived: sum of 2 quarters · filed 2026-03-11 | $269.00K derived: sum of 3 quarters · filed 2026-08-06 | $352.00K 10-K · filed 2026-03-11 | ||
| 2025-09-30 | $88.00K 10-Q · filed 2025-11-14 | $169.00K derived: sum of 2 quarters · filed 2026-08-06 | $252.00K 10-Q · filed 2025-11-14 | $390.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $81.00K 10-Q · filed 2026-08-06 | $165.00K 10-Q · filed 2026-08-06 | $302.00K derived: sum of 3 quarters · filed 2026-08-06 | $489.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $84.00K 10-Q · filed 2026-05-12 | $221.00K derived: sum of 2 quarters · filed 2026-05-12 | $408.00K derived: sum of 3 quarters · filed 2026-05-12 | $564.00K derived: sum of 4 quarters · filed 2026-05-12 | ||
| 2024-12-31 | $137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $324.00K derived: sum of 2 quarters · filed 2026-03-11 | $480.00K derived: sum of 3 quarters · filed 2026-03-11 | $619.00K 10-K · filed 2026-03-11 | ||
| 2024-09-30 | $187.00K 10-Q · filed 2025-11-14 | $343.00K derived: sum of 2 quarters · filed 2025-11-14 | $482.00K 10-Q · filed 2025-11-14 | $501.00K derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | $156.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $294.00K 10-Q · filed 2025-08-12 | $314.00K derived: sum of 3 quarters · filed 2025-08-12 | $315.00K derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $138.00K 10-Q · filed 2025-05-13 | $158.00K derived: sum of 2 quarters · filed 2025-05-13 | $159.00K derived: sum of 3 quarters · filed 2025-05-13 | $159.00K derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $21.00K derived: sum of 2 quarters · filed 2025-03-11 | $21.00K derived: sum of 3 quarters · filed 2025-03-11 | $20.00K 10-K · filed 2025-03-11 | ||
| 2023-09-30 | $1.00K 10-Q · filed 2023-11-09 | $1.00K derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2024-11-05 | $1.00K 10-Q · filed 2023-11-09 | -$3.00K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 | $0.00 10-Q · filed 2024-08-14 | -$4.00K derived: sum of 3 quarters · filed 2024-05-13 | -$3.00K derived: sum of 4 quarters · filed 2024-05-13 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-13 | -$4.00K derived: sum of 2 quarters · filed 2024-05-13 | -$3.00K derived: sum of 3 quarters · filed 2024-05-13 | -$1.00K derived: sum of 4 quarters · filed 2024-05-13 | ||
| 2022-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$3.00K derived: sum of 2 quarters · filed 2024-02-29 | -$1.00K derived: sum of 3 quarters · filed 2024-02-29 | $0.00 10-K · filed 2024-02-29 | $4.00K 10-K · filed 2023-03-06 | |
| 2022-09-30 | $1.00K 10-Q · filed 2023-11-09 | $3.00K derived: sum of 2 quarters · filed 2023-11-09 | $4.00K 10-Q · filed 2023-11-09 | $7.00K derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $2.00K 10-Q · filed 2023-08-08 | $3.00K 10-Q · filed 2023-08-08 | $6.00K derived: sum of 3 quarters · filed 2023-08-08 | $8.00K derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | $2.00K 10-Q · filed 2023-05-09 | $4.00K derived: sum of 2 quarters · filed 2023-05-09 | $6.00K derived: sum of 3 quarters · filed 2023-05-09 | $7.00K derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $4.00K derived: sum of 2 quarters · filed 2023-03-06 | $5.00K derived: sum of 3 quarters · filed 2023-03-06 | $5.00K 10-K · filed 2023-03-06 | ||
| 2021-09-30 | $2.00K 10-Q · filed 2022-11-07 | $3.00K derived: sum of 2 quarters · filed 2022-11-07 | $3.00K 10-Q · filed 2022-11-07 | |||
| 2021-06-30 | $1.00K 10-Q · filed 2022-08-11 | $1.00K 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |